BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

626 related articles for article (PubMed ID: 18613857)

  • 1. Prevalence of possible drug-drug interactions between antiretroviral agents in different age groups in a section of the private health care sector setting in South Africa.
    Katende-Kyenda NL; Lubbe MS; Serfontein JH; Truter I
    J Clin Pharm Ther; 2008 Aug; 33(4):393-400. PubMed ID: 18613857
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of potential drug-drug interactions between antiretroviral drugs from prescriptions in the private health-care sector in South Africa.
    Katende-Kyenda NL; Lubbe MS; Serfontein JH; Truter I
    Int J STD AIDS; 2012 Mar; 23(3):166-72. PubMed ID: 22581868
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence of drug-drug interactions of antiretroviral agents in the private health care sector in South Africa.
    Katende-Kyenda NL; Lubbe MS; Serfontein JH; Truter I
    S Afr Med J; 2008 Feb; 98(2):109-13. PubMed ID: 18350204
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antiretroviral drug dosing errors in HIV-infected patients undergoing hemodialysis.
    Tourret J; Tostivint I; Tézenas Du Montcel S; Karie S; Launay-Vacher V; Vigneau C; Bessette C; Deray G; Bagnis CI
    Clin Infect Dis; 2007 Sep; 45(6):779-84. PubMed ID: 17712764
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A high incidence of lactic acidosis and symptomatic hyperlactatemia in women receiving highly active antiretroviral therapy in Soweto, South Africa.
    Bolhaar MG; Karstaedt AS
    Clin Infect Dis; 2007 Jul; 45(2):254-60. PubMed ID: 17578788
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A survey of the syntheses of active pharmaceutical ingredients for antiretroviral drug combinations critical to access in emerging nations.
    Pinheiro Edos S; Antunes OA; Fortunak JM
    Antiviral Res; 2008 Sep; 79(3):143-65. PubMed ID: 18571246
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antiretrovial (ARV) drug utilisation in Harare.
    Nyazema NZ; Khoza S; Landman I; Sibanda E; Gael K
    Cent Afr J Med; 2000 Apr; 46(4):89-93. PubMed ID: 11210341
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antiretroviral drug interactions: often unrecognized, frequently unavoidable, sometimes unmanageable.
    Seden K; Back D; Khoo S
    J Antimicrob Chemother; 2009 Jul; 64(1):5-8. PubMed ID: 19398457
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence and predictors of potential drug-drug interactions in Regione Emilia-Romagna, Italy.
    Gagne JJ; Maio V; Rabinowitz C
    J Clin Pharm Ther; 2008 Apr; 33(2):141-51. PubMed ID: 18315779
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Recommendations from the GESIDA/Spanish AIDS Plan regarding antiretroviral treatment in adults with human immunodeficiency virus infection (update February 2009)].
    Panel de expertos de Gesida y Plan Nacional sobre el Sida
    Enferm Infecc Microbiol Clin; 2009 Apr; 27(4):222-35. PubMed ID: 19246124
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Impact of antiretroviral therapy in mortality of Chilean HIV (+) patients: a case control study].
    Wolff M; Bustamante C; Bidart T; Dabanch J; Diomedi A; Northland R
    Rev Med Chil; 2000 Aug; 128(8):839-45. PubMed ID: 11129544
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High frequency of highly active antiretroviral therapy modifications in patients with acute or early human immunodeficiency virus infection.
    Sabundayo BP; McArthur JH; Langan SJ; Gallant JE; Margolick JB
    Pharmacotherapy; 2006 May; 26(5):674-81. PubMed ID: 16637796
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of rosiglitazone treatment on the bioavailability of antiretroviral compounds in HIV-positive patients.
    Oette M; Kurowski M; Feldt T; Kroidl A; Sagir A; Vogt C; Wettstein M; Häussinger D
    J Antimicrob Chemother; 2005 Aug; 56(2):416-9. PubMed ID: 15983027
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Concomitant use of gastric acid-reducing agents is frequent among HIV-1-infected patients receiving protease inhibitor-based highly active antiretroviral therapy.
    van Lunzen J; Liess H; Arastéh K; Walli R; Daut B; Schürmann D
    HIV Med; 2007 May; 8(4):220-5. PubMed ID: 17461849
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of antiretroviral HIV post-exposure prophylaxis in sexually abused children and adolescents treated in an inner-city pediatric emergency department.
    Fajman N; Wright R
    Child Abuse Negl; 2006 Aug; 30(8):919-27. PubMed ID: 16939690
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of the prescribing of potentially inappropriate medications at ambulatory care visits by elderly patients covered by the Taiwanese National Health Insurance program.
    Lai HY; Hwang SJ; Chen YC; Chen TJ; Lin MH; Chen LK
    Clin Ther; 2009 Aug; 31(8):1859-70. PubMed ID: 19808145
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Methylphenidate: prescribing patterns in a South African primary care patient population.
    Truter I
    J Clin Pharm Ther; 2005 Feb; 30(1):59-63. PubMed ID: 15659004
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacologic consideration for the use of antiretroviral agents in the elderly.
    Rhee MS; Greenblatt DJ
    J Clin Pharmacol; 2008 Oct; 48(10):1212-25. PubMed ID: 18812611
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HIV infection and advanced age emerging epidemiological, clinical, and management issues.
    Manfredi R
    Ageing Res Rev; 2004 Jan; 3(1):31-54. PubMed ID: 15164725
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Factors affecting antiretroviral drug adherence among HIV/AIDS adult patients attending HIV/AIDS clinic at Moi Teaching and Referral Hospital, Eldoret, Kenya.
    Talam NC; Gatongi P; Rotich J; Kimaiyo S
    East Afr J Public Health; 2008 Aug; 5(2):74-8. PubMed ID: 19024414
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.